Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

CRON Stock Could Ride the Cannabis Resurgence into a Year-Long Rally

By Luke Lango, InvestorPlace Senior Investment Analyst
As a high-quality pick in a resurgent cannabis sector, CRON stock could be due for big returns in calendar 2020.

Why Canopy Growth Stock Holding $20 Might Go Up in Smoke

By Chris Lau, InvestorPlace Contributor
Canopy Growth’s prospects in 2020 look much like last year’s, but growing store count and Cannabis 2.0 might help Canopy Growth stock.

Hexo Stock May Bottom Here, but It Probably Won’t

By Luke Lango, InvestorPlace Senior Investment Analyst
Pot stocks will rebound in 2020, but HEXO stock may not join the party, as growth trends remain pressured by competition.

Here’s Why It’s Not Too Late to Buy Canopy Growth Stock

By Chris Tyler, InvestorPlace Contributor
A major bottom is in, but there’s a better way to play Canopy Growth stock than buying shares today.

Should Investors Buy Aurora Stock in 2020?

By Tezcan Gecgil, InvestorPlace Contributor
ACB stock may continue to be punished until it becomes consistently profitable and improves cash flow

Stock Market Today: Jobs Disappoint, Aurora Cannabis Stock to $1? 

By Bret Kenwell, InvestorPlace Contributor
Six Flags cratered, the jobs report disappointed and Aurora Cannabis could have big downside. Here's what happened in the stock market today.

Could the Pain Finally Be Over for Canopy Growth Stock?

By Tezcan Gecgil, InvestorPlace Contributor
After a dismal 2019, the owners of CGC stock are hoping for sunnier days ahead. Will Canopy Growth stock come through for them?

Two Key Questions for Canopy Growth Stock in 2020

By Vince Martin, InvestorPlace Contributor
2019 was an ugly year for Canopy Growth stock. CGC can rebound in 2020 if it can capitalize on key opportunities.

It Doesn’t Look as If the ACB Stock Turnaround Is Coming Any Time Soon

By Jamie Johnson
After struggling in 2019, investors are hoping for a fresh start for Aurora stock. Here are a few things you need to know about ACB stock.

Canopy Growth Stock Looks Ready to Gain From Big Catalysts in 2020

By Ian Cooper, InvestorPlace Contributor
Canopy Growth stock investors are excited about a new CEO at the helm and new Cannabis 2.0 products on the way. CGC stock looks primed for 2020.

What Hexo Stock Needs Is Some Old-Fashioned Reaganomics

By Josh Enomoto, InvestorPlace Contributor
Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.

Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth

By Tyler Craig, Tales of a Technician
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.

Aurora Stock Will Have Another Rough Year

By Marie Brodbeck, InvestorPlace Contributor
The shaky financials of Aurora stock make ACB stock one of the worst choices in the marijuana industry.

There’s No World Where ACB Stock Plummets to Nothing

By Wayne Duggan, InvestorPlace Contributor
One analyst recently made a bold prediction that ACB stock is completely worthless. While Aurora remains an extremely risky bet, the stock will never make it to $0.

Is Canopy Growth a Worthy Investment in 2020?

By Bret Kenwell, InvestorPlace Contributor
Canopy Growth has been hammered in 2019, along with the the rest of the cannabis space. Is a rebound ready to go?

Here’s Why You Should Pay More, Not Less for Aphria Stock

By Chris Tyler, InvestorPlace Contributor
Aphria stock is already delivering on the bottom line for its shareholders. It's also shaping up to deliver big profits in 2020.

Can Canopy Growth Rise Above the Cannabis Industry’s Reputation?

By Josh Enomoto, InvestorPlace Contributor
The cannabis industry suffered horribly in 2019 and Aurora Cannabis’ controversial executive departure creates a trust issue for Canopy Growth and other major players.

U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020

By InvestorPlace Staff
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.

Is Aphria the Best Cannabis Stock to Buy?

By Bret Kenwell, InvestorPlace Contributor
Aphria stock has some of the best financials in the cannabis space, but that hasn't stopped APHA stock from getting hit like its peers.
Load More